check_circleStudy Completed

Dysmenorrhea

Bayer Identifier:

Trial_CC-00138

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
Study to compare the analgesic efficacy and safety of Naproxen Sodium and Ibuprofen for the treatment of dysmenorrhea

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

Female

Age

16 - N/A
  • -

  • -

Trial summary

Enrollment Goal
79
Trial Dates
December 1995 - March 1996
Phase
Phase 3
Could I Receive a placebo
N/A
Products
Aleve (Naproxen Sodium, BAY117031)
Accepts Healthy Volunteer
N/A

Trial design

A randomised double blind multiple dose study to compare the analgesic efficacy and safety of Naproxen Sodium 220 mg and Ibuprofen 200 mg for the treatment of dysmenorrhoea
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.